Results 81 to 90 of about 337,957 (243)

Myocardial stunning, hibernation, and ischemic preconditioning

, 1996
From the present review, it may be concluded that myocardial ischemia results in far more complicated syndromes than previously realized. Although not all aspects of the issues discussed in this review are currently a clinical reality in the daily ...
van Wezel, H. B., Vroom, M. B.
core   +1 more source

Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York

ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao   +5 more
wiley   +1 more source

‘Broken heart’ in acute-on-chronic liver failure

Proceedings of Singapore Healthcare, 2017
Takotsubo cardiomyopathy usually occurs as a result of catecholamine release causing myocardial ‘stunning’ during physical or emotional stress. Typically coronary angiogram shows normal or minor coronary artery disease and echocardiogram shows apical ...
Ennaliza Salazar, Chee Kiat Tan, George Boon Bee Goh   +2 more
doaj   +1 more source

A flow-limiting stenosis is the major determinant of exercise-induced myocardial stunning in patients with coronary artery disease [PDF]

, 2010
SummaryBackgroundAlthough stress-induced myocardial stunning often develops after exercise testing, determinants of this phenomenon have not been evaluated.Methods and resultsThirty-one patients with 1-vessel coronary artery disease, limited to the left ...
Hida, Satoshi, Chikamori, Taishiro, Tanaka, Hirokazu, Igarashi, Yuko, Shindo, Naohisa, Tanaka, Nobuhiro, Yamashina, Akira   +6 more
core   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Towards the humane slaughter of decapod crustaceans: identifying the most effective indicators of insensibility following electrical stunning [PDF]

Decapod crustaceans provide a valuable food source worldwide, both through wild capture and captive rearing. They are also used extensively in scientific research, both as subjects for the investigation of basic biological processes and as model ...
Albalat, Amaya, Neil, Douglas M, Endre Putyora, Douglas M. Neil, Neil, Douglas M., Putyora, Endre, Amaya Albalat   +6 more
core   +1 more source

Myocardial dysfunction after resuscitation from cardiac arrest: An example of global myocardial stunning [PDF]

, 1996
Objectives. This study investigated the effect of prolonged cardiac arrest and subsequent cardiopulmonary resuscitation on left ventricular systolic and diastolic function.Background.
Ronald W. Hilwig, Rhee, Kyoo H., Robert A. Berg, Karl B. Kern, Hilwig, Ronald W., Berg, Robert A., Kyoo H. Rhee, Kern, Karl B.   +7 more
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

ESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén, Bård Andre Bendiksen, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Gary McGinley, Almira Hasic, Ida Marie Hauge‐Iversen, Hege Katrin Ugland, Xin Shen, Michael Frisk, Nishani S. Mabotuwana, William E. Louch, Rizwan I. Hussain, Lili Zhang, Ivar Sjaastad, Alessandro Cataliotti, Geir Christensen   +16 more
wiley   +1 more source

Role of apoptosis in myocardial stunning after open heart surgery

, 2002
Background. Myocardial preservation during open heart surgery is a subject of intense investigation. A prerequisite for further improvement is a better understanding of the underlying pathophysiologic mechanisms responsible for postoperative myocardial ...
Schmitt, Joachim P, Birnbaum, Dietrich E, Schunkert, Heribert, Schröder, Josef, Aebert, Hermann   +4 more
core   +1 more source